Connect with us
The response to Covid-19 by governments and the medical community demonstrated the possibilities of rapid testing and vaccine development. Now one company, Alercell, is looking to...
As vaccine sales for Novavax, Moderna, and BioNTech shift in line with a changing Covid-19 situation, the results are being felt in the stock markets. Here...
The new transaction is aimed at equipping Lipogems with the necessary resources to accelerate the development of therapies for priority clinical indications, primarily knee osteoarthritis, for...
Grifols and Pharma Mar reduced profits, while Reig Jofre, Faes Farma, Rovi and Almirall increased their profits between January and June. This last company has exceeded...
Mediquo has recently closed a financing round and plans to make to leap to Mexico. Most of the company's existing partners participated in this round, in...
Heuristik has developed software that combines fingerprint recognition with AI. This solution is aimed at managing patient portfolio data, but also envisages the possibility of being...
Ceres Demeter, a company that researches and develops biological products for companies in the agricultural sector, plans to allocate these funds to the expansion and modernization...
Able has designed a robotic exoskeleton for people with disabilities. In Germany, Able's CEO highlights the fact that the company has carried out part of the...
The company, founded in 2015, although the project started in 2017, raised $601,000 (€600,000)in January 2021 to start the process of clinical validation of its device....
Moderna is now advancing two bivalent candidates for fall, based on differing market preferences for Omicron subvariants. The bivalent booster mRNA-1273.214 is the only candidate that...
 |
|
 |  |
 |
|